CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

SANOFI CONSUMER HEALTHCARE INDIA LTD.

NSE : SANOFICONRBSE : 544250ISIN CODE : INE0UOS01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE4584.60-11.6 (-0.25 %)
PREV CLOSE () 4596.20
OPEN PRICE () 4624.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 118
TODAY'S LOW / HIGH ()4557.20 4624.45
52 WK LOW / HIGH ()4360.3 5954
NSE4591.40-25.8 (-0.56 %)
PREV CLOSE() 4617.20
OPEN PRICE () 4598.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 828
TODAY'S LOW / HIGH() 4565.20 4607.70
52 WK LOW / HIGH ()4537.45 5894.5
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2023

Management Info :

Amit Jain - Chairman Himanshu Bakshi - Managing Director

Registered Office :

Address : Unit 1104, 11th Floor, Godrej Two,Pirojshanagar, Eastern Express Highway,Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone : 022 45288855

Website : www.sanofi.in

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
10Oct Sanofi Consumer Healthcare India inf
In accordance with Regulation 30 of the SEBI (Listing Obligations and Di..
05Aug Sanofi Consumer Healthcare India repor
Sanofi Consumer Healthcare India has reported result for second quarter..
05Aug Sanofi Consumer Healthcare India zooms
Sanofi Consumer Healthcare India is currently trading at Rs. 5319.55, up..
13Jun Sanofi Consumer Healthcare India infor
Sanofi Consumer Healthcare India has informed that the exchange has rece..
11Apr Sanofi Consumer Healthcare India infor
Pursuant to Regulation 26(7) of the SEBI (Substantial Acquisition of Sha..
Financials
in Millions
QTR Sep 25 ANNUAL 24
Net Profit6291810
Gross Profit 841 2468
Operating Profit 8802836
Net Sales 23397245
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
CORONA Remedies (BSE)
 1437.20 (35.33%)
M.Cap ( in Cr)
8789.93
Neuland Laboratories (BSE)
 16421.90 (2.15%)
M.Cap ( in Cr)
21069.12
Procter&Gamble Healt (BSE)
 5675.85 (1.74%)
M.Cap ( in Cr)
9421.56
Fredun Pharma (BSE)
 1660.40 (5.00%)
M.Cap ( in Cr)
783.98
RPG Life Sciences (BSE)
 2372.25 (2.78%)
M.Cap ( in Cr)
3923.47
Shareholding Pattern
PROMOTERS 71.27%
MUTUAL FUNDS/UTI 13.34%
NON-INSTITUTION 8.58%
FI/BANKS/INSURANCE 3.87%
FII 0.01%
GOVERNMENT 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX85213.36-54.30 (-0.06%)
NIFTY26027.30-19.65 (-0.08%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI